Access to National Market Share Data -CIRCANA

The contract aims to secure access to comprehensive national retail sales scanner data encompassing the entire U.S. market over the past five rolling years. This data, provided by CIRCANA, will enable the FDA to continuously monitor packaged consumer goods, enhancing its ability to conduct real-time post market surveillance. The access supports the FDA in performing more accurate and high-quality analyses, research, and publications related to post market studies, which will ultimately guide policy decisions and regulatory actions. By leveraging this enterprise-level data solution, the FDA intends to improve the identification and tracking of emerging public health benefits and threats associated with FDA-regulated products. The data will facilitate timely and appropriate responses to ensure product safety and protect public health. This acquisition reflects a cost-effective approach to supplementing existing post market information, enabling the FDA to fulfill its regulatory responsibilities with improved precision and efficiency.